Regulated Information - Global

Filter

Period

Filter by

Reset

Showing: 1 – 05 of 148 Regulated Information

Show

Sort

Combined Shareholders’ Meeting of 24 May 2022

03 May 2022

03 May 2022

Combined Shareholders’ Meeting of 24 May 2022

Ipsen delivers a strong sales performance in the first quarter of 2022

27 April 2022

27 April 2022

Ipsen delivers a strong sales performance in the first quarter of 2022

Q1 2022 – Sales presentation (0 bytes)

Webcast Q1 2022

Ipsen presents strong full-year 2021 results and enters into exclusive negotiations to divest its Consumer Healthcare business

11 February 2022

11 February 2022

Ipsen presents strong full-year 2021 results and enters into exclusive negotiations to divest its Consumer Healthcare business

Attachment

FY 2021 – Results presentation (0 bytes)

Webcast replay FY 2021

Ipsen and GENFIT enter into exclusive licensing agreement for elafibranor, a Phase III asset evaluated in Primary Biliary Cholangitis, as part of a long-term global partnership

17 December 2021

17 December 2021

Ipsen and GENFIT enter into exclusive licensing agreement for elafibranor, a Phase III asset evaluated in Primary Biliary Cholangitis, as part of a long-term global partnership

Ipsen delivers strong sales growth for the first nine months and improves its full-year guidance

21 October 2021

21 October 2021

Ipsen delivers strong sales growth for the first nine months and improves its full-year guidance

YTD 2021 – Sales presentation (0 bytes)

1 … 24 25 26 27 28 29 30

♿

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.